FTFinancial Times·2hBusiness
score+0.50
Novo buys rights to Chinese weight-loss pill in $2.6bn deal
Original
Novo buys rights to Chinese weight-loss pill in $2.6bn deal
“Focuses on the strategic acquisition and the convenient weekly dosing feature, signaling positive market and product advancements.”